Kangmei Pharma | 600518 - Cost Of Sales

Stock Price
1.76
Daily Change
-0.03 -1.68%
Monthly
-6.38%
Yearly
-12.00%
Q2 Forecast
1.71

Kangmei Pharma reported CNY1.11B in Cost of Sales for its fiscal quarter ending in September of 2025.





Cost Of Sales Change Date
Akebia Therapeutics USD 10.34M 441K Dec/2025
Alaunos Therapeutics USD 0 18K Sep/2024
Avita Medical AUD 3.3M 166K Dec/2025
Cspc Pharmaceutical CNY 2.11B 173.58M Dec/2025
Genomma Lab Internacional MXN 1.57B 37.54M Dec/2025
Hypermarcas BRL 858.94M 6.26M Dec/2025
Ionis Pharmaceuticals USD 8M 5.66M Dec/2025
IQVIA Holdings USD 3.24B 518M Dec/2025
Jiangsu Hengrui CNY 1.17B 86.74M Dec/2025
Kangmei Pharma CNY 1.11B 84.66M Sep/2025
Moderna USD 452M 245M Dec/2025
Organon & Co USD 745M 25M Sep/2025
Revvity USD 350.4M 26.05M Dec/2025
Sh Fosun Pharma CNY 5.57B 492.91M Dec/2025
Viatris USD 2.56B 167.3M Dec/2025
Wuxi Apptec CNY 6.26B 64.7M Dec/2025
Xeris Pharmaceuticals USD 13.66M 49K Dec/2025
Zz Pientze Pharmaceu CNY 1.34B 601.08M Sep/2025